glutathione s-transferase GST Glutathione-S-Transferases as Potential Targets for

However, severe side effects and poor target specificity remain major obstacles for the development of copper complexes as anticancer drugs

10.1146/annurev-clinpsy-032813-153716 Pubmed Abstract CrossRef Google Scholar View reference in article 24 Granados-MartinezC.Alfageme-LopezN.Navarro-OviedoM.Nieto-VaqueroC.CuarteroM

Damaged-on-arrival claims must be reported promptly after delivery and may require photos, packaging details, and order information for review

G., McCrea, M

Dose ranges for different goals The KLOW dosing literature suggests a range from approximately 2.7mg to 8mg total peptide daily, depending on goals and individual response

[DOI] [PMC free article] [PubMed] [Google Scholar] 137